Attribution

Provision of non-residential Property Consultancy and Advice, Property Related Client Representation and Assistance and Ancillary Services related to 30 Churchill Place, Canary Wharf, London

Name: Provision of non-residential Property Consultancy and Advice, Property Related Client Representation and Assistance and Ancillary Services related to 30 Churchill Place, Canary Wharf, London
Creator: European Medicines Agency, MED - European Medicines Agency
Published: 2025-12-18
License: https://ted.europa.eu/en/simap/legal-notice

Suivre cette ficheCompte gratuit — soyez alerté dès qu’un marché arrive à échéance.

Acheteur: European Medicines Agency, MED - European Medicines Agency
Titulaires: BNP PARIBAS REAL ESTATE ADVISORY &PROPERTY MANAGEMENT UK LIMITED
Montant du marché: aucun montant publié
Publié le: 18 déc. 2025
Attribution: 16 déc. 2025
Début d'exécution: 16 déc. 2025
Fin du marché: 15 déc. 2027estimée
Secteur: Services immobiliers
Région: Groot-Amsterdam
Source: Avis d'origine sur TED (848982-2025)

Autres attributions de cet acheteur

Attribution	Acheteur	Titulaire	Montant du marché	Publié le
Data Management- Anonymization and redaction of documents and datasets	European Medicines Agency, MED - European Medicines Agency	IQVIA Solutions Belgium B.V., Syneos Health Clinical Spain, S.L.U.	—	4 sept. 2026
LOT 7: Computational methods for comparison of molecular structural features in the context of medicines for rare diseases	European Medicines Agency, MED - European Medicines Agency	Istituto di Ricerche Farmacologiche Mario Negri, KREATIS	—	1 sept. 2026
LOT 6: Innovative technologies for manufacturing and quality control of medicines	European Medicines Agency, MED - European Medicines Agency	NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED, RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH, UNIVERSITA DEGLI STUDI DI MILANO	—	1 sept. 2026
LOT 5: Pharmacoepidemiological research	European Medicines Agency, MED - European Medicines Agency	Agora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL +15 autres	—	1 sept. 2026
LOT 4: Qualitative research	European Medicines Agency, MED - European Medicines Agency	NHG Finland Oy, NIVEL, Oracle France S.A.S. +2 autres	—	1 sept. 2026
LOT 3: Methodological/statistical research	European Medicines Agency, MED - European Medicines Agency	Agentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 autres	—	1 sept. 2026